AMETEK (NYSE:AME – Get Rating) had its price objective decreased by stock analysts at KeyCorp from $155.00 to $145.00 in a note issued to investors on Wednesday, The Fly reports. KeyCorp’s price target indicates a potential upside of 16.64% from the company’s previous close.
AME has been the subject of several other research reports. Zacks Investment Research upgraded shares of AMETEK from a “sell” rating to a “hold” rating and set a $134.00 target price for the company in a research report on Tuesday, April 19th. Morgan Stanley dropped their target price on shares of AMETEK from $159.00 to $158.00 and set an “overweight” rating for the company in a research report on Friday, January 14th. Finally, StockNews.com assumed coverage on shares of AMETEK in a report on Thursday, March 31st. They issued a “hold” rating for the company. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $149.30.
AME stock opened at $124.31 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.36 and a quick ratio of 0.87. The company has a 50 day moving average price of $130.38 and a 200 day moving average price of $135.44. AMETEK has a fifty-two week low of $121.80 and a fifty-two week high of $148.07. The stock has a market capitalization of $28.74 billion, a PE ratio of 29.25, a price-to-earnings-growth ratio of 2.49 and a beta of 1.26.
In other news, Director Thomas A. Amato sold 615 shares of the stock in a transaction dated Monday, March 28th. The shares were sold at an average price of $133.03, for a total transaction of $81,813.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Anthony James Conti sold 5,160 shares of the stock in a transaction dated Friday, March 25th. The stock was sold at an average price of $133.37, for a total transaction of $688,189.20. The disclosure for this sale can be found here. 0.72% of the stock is currently owned by corporate insiders.
Several institutional investors have recently bought and sold shares of the company. Amundi Pioneer Asset Management Inc. raised its holdings in shares of AMETEK by 16.2% in the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 242,237 shares of the technology company’s stock valued at $20,098,000 after purchasing an additional 33,825 shares during the period. Shell Asset Management Co. raised its holdings in shares of AMETEK by 3.7% in the 3rd quarter. Shell Asset Management Co. now owns 4,929 shares of the technology company’s stock valued at $611,000 after purchasing an additional 178 shares during the period. Advisor Group Holdings Inc. raised its holdings in shares of AMETEK by 3.0% in the 3rd quarter. Advisor Group Holdings Inc. now owns 31,477 shares of the technology company’s stock valued at $3,903,000 after purchasing an additional 912 shares during the period. Advisory Services Network LLC raised its holdings in shares of AMETEK by 13.3% in the 3rd quarter. Advisory Services Network LLC now owns 3,796 shares of the technology company’s stock valued at $471,000 after purchasing an additional 446 shares during the period. Finally, Los Angeles Capital Management LLC raised its holdings in shares of AMETEK by 1.8% in the 3rd quarter. Los Angeles Capital Management LLC now owns 94,853 shares of the technology company’s stock valued at $11,763,000 after purchasing an additional 1,686 shares during the period. Institutional investors own 86.72% of the company’s stock.
AMETEK Company Profile (Get Rating)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.
- Get a free copy of the StockNews.com research report on AMETEK (AME)
- 3 Earnings Plays With Big Move Potential
- There Are Weeds In The Garden At Scotts Miracle-Gro
- It’s Time For FuboTV to Stand Out in the Sea of Streaming
- Landstar Systems Stock Can Bottom Down Here
- 3M Stock is Worth a Look Because of the Company it Keeps
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.